Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

47 results about "Aromatic hydrocarbon receptor" patented technology

Approximately 280kD soluble protein complex; binds and mediates carcinogenesis by polycyclic aromatic hydrocarbons, heterocyclic amines, and chlorinated aromatic compounds.

Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells

The present invention relates to methods, kits and compositions for expansion of hematopoietic stem / progenitor cells and providing hematopoietic function to human patients in need thereof. In one aspect, it relates to kits and compositions comprising a Notch agonist and an aryl hydrocarbon receptor antagonist. Also provided herein are methods for expanding the hematopoietic stem / progenitor cells using kits and compositions comprising a Notch agonist and an aryl hydrocarbon receptor antagonist. The hematopoietic stem / progenitor cells expanded using the disclosed kits, compositions and methods include human umbilical cord blood stem / progenitor cells, placental cord blood stem / progenitor cells and peripheral blood stem cells. The present invention also relates to administering hematopoietic stem / progenitor cells expanded using a combination of a Notch agonist and an aryl hydrocarbon receptor antagonist to a patient for short-term and / or long-term in vivo repopulation benefits.
Owner:NOVARTIS AG +1

Indirubin-Type Compounds, Compositions, and Methods for Their Use

Compounds and compositions including 6-bromo-indirubin, 5-amino-indirubin and N-methyl-indirubins and related indirubin derivatives are provided that are useful as selective modulators of glycogen synthase kinase-3, cyclin-dependent protein kinases or aryl hydrocarbon receptors. Methods of inhibiting or modulating cell growth or cell cycling are provided using the compounds of the invention. In other aspects, compounds and methods for the treatment of protozoan-mediated diseases, Alzheimer's disease and diabetes are provided.
Owner:MEIJER LAURENT +3

Malassezin and analogs thereof as skin brightening agents

ActiveUS20170260133A1Cosmetic preparationsOrganic chemistryReceptorHyperpigmentation disorder
The present invention relates to compounds, compositions, and methods for brightening skin. The compounds, compositions, and methods of the present invention generally involve compounds produced by a Malassezia yeast, and chemical analogs thereof. In addition to skin brightening applications, the compounds, compositions, and methods of the present invention may be used to modulate melanocyte activity, induce melanocyte apoptosis, agonize an arylhydrocarbon receptor (AhR), improve hyperpigmentation caused by a hyperpigmentation disorder, and modulate melanin production, melanosome biogenesis, and melanosome transfer.
Owner:VERSICOLOR TECH LLC

Application of evodiamine in preparing medicine for inhibiting aryl hydrocarbon receptor

The invention relates to application of evodiamine in preparing a medicine for inhibiting an aryl hydrocarbon receptor. The medicine for inhibiting the aryl hydrocarbon receptor has the anti-tumor and immunoregulation effects by inhibiting the aryl hydrocarbon receptor, wherein the tumors are breast cancer, endometrial cancer, prostate cancer, lung cancer, gastric cancer, liver cancer, colon cancer and the like; and the immunoregulation is performed aiming at various inflammatory related diseases, such as sepsis, sepsis shock, rheumatic arthritis, rheumatoid arthritis, asthma, acute and chronic glomerulonephritis, and systemic lupus erythematosus. In the application, the evodiamine is an alkaloid component in a traditional Chinese medicine, namely medicinal evodia fruit, has the molecular formula of C19H17NO3 and the molecular weight of 303.4Da, is insoluble, can be dissolved in organic solvents such as dimethyl sulfoxide, ethanol, diethyl ether and chloroform, and has the melting point of 278 to 279 DEG C.
Owner:THE THIRD AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIV OF PLA

Method for detecting plasmids of polycyclic aromatic hydrocarbons in environment and application thereof

The invention discloses a method for detecting plasmids of polycyclic aromatic hydrocarbons in an environment and an application thereof, and relates to the fields of molecular biology and environmental biotechnology. According to the method provided by the invention, by extracting the promoter of a humanized AHR (Aromatic Hydrocarbon Receptor) gene, using a CV060 plasmid including a firefly luciferase and renilla luciferase reporter gene as a carrier and inserting the AHR gene promoter with a specific sequence, a recombined lentivirus plasmid of a reference internal type dual-luciferase reporter gene including the AHR gene promoter is built. The detection method provided by the invention is good in repeatability, high in sensitivity, reliable in detection result, and simple and convenient to operate, and can be widely applied to the detection of the polycyclic aromatic hydrocarbons in the environment.
Owner:NANJING MEDICAL UNIV

Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr)

The invention provides a human AHR which is associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, respiratory diseases, urological diseases and gastroenterological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, respiratory diseases, urological diseases and gastroenterological diseases. The invention also features compounds which bind to and / or activate or inhibit the activity of AHR as well as pharmaceutical compositions comprising such compounds.
Owner:BAYER HEALTHCARE AG

Composition for preventing inflammations

The purpose of the present invention is to provide a probiotic(s) which can activate an aromatic hydrocarbon receptor (AhR) and can consequently prevent inflammatory damage in the digestive tract. The present invention relates to; a probiotic(s) capable of activating an AhR; an anti-inflammatory agent comprising the probiotic(s); an orally ingestible composition containing the anti-inflammatory agent; and a method for screening for the probiotic(s).
Owner:MEIJI CO LTD

Carrier suitable for cell transformation, recombinant cell and application thereof

The invention provides a carrier suitable for cell transformation, a recombinant cell and an application thereof, wherein a group of carriers suitable for cell transformation comprise a first carrier and a second carrier. The first carrier comprises a first nucleic acid sequence; the first nucleic acid sequence comprises a sequence coding report protein; and the report protein has detectable activity; the first nucleic acid sequence also comprises a dioxin response region which comprises a dioxin response element; and the dioxin response region is operably connected with the first nucleic acid sequence. The second carrier comprises a second nucleic acid sequence, and the second nucleic acid sequence comprises a sequence coding an aromatic hydrocarbon receptor. The carrier suitable for cell transformation and the recombinant cell of the invention are applicable to detection of dioxin compounds.
Owner:SHENZHEN HUADA GENE INST +1

Methods of inhibiting the activity of hsp90 and/or aryl hydrocarbon receptor

The present invention relates to a method of screening compounds for binding to hsp90 by exposing a compound to hsp90 or a polypeptide fragment thereof containing amino acid residues 538-728 of the full length protein and determining whether the compound binds to hsp90 of the polypeptide fragment thereof. Also disclosed is a method of screening compounds for inhibition of hsp90 activity. The present invention further relates to a method of screening compounds as a cancer therapeutic and a method of treating cancerous conditions. Also disclosed is a method of inhibiting transcription-inducing activity of an aryl hydrocarbon receptor in a cell and a method of modifying expression of a gene that is activated by an aryl hydrocarbon receptor.
Owner:UNIVERSITY OF ROCHESTER

Aromatic hydrocarbon receptor modulator

The invention discloses an aromatic hydrocarbon receptor modulator shown in a formula (I) and a pharmaceutically acceptable salt thereof. The formula (I) is described in the specification, wherein R'is H, CN, CH2(OH)RO, CmH2m+1, CnH2n-1, CnH2n-3 or two groups (described in the specification), and two Ra groups are independently H or jointly form =O or =N-W3-R1; A is a C6-C10 aromatic ring unsubstituted or with 1-3 R substituted, a C2-C10 heteroaromatic ring mixed with 1-5 heteroatoms selected from N, O and S or a quaternary to heptatomic nonaromatic heterocyclic ring which is mixed with 1-3 heteroatoms selected from N, O and S and contains C=N; Q is R, or a C6-C10 aromatic ring unsubstituted or with 1-3 R substituted, or a C2-C10 heteroaromatic ring mixed with 1-5 heteroatoms selected from N, O and S; and R is RC connected with C or RN connected with N. The compound shown in a formula (I) can regulate AhR activity and can be used for inhibiting cancer cell growth as well as migrationand invasion of tumor cells.
Owner:ARIAGEN INC

Cells and methods for estimation of effects on neurological dysfunction

The invention provides neuron-derived cells obtained by transfecting a receptor-expressing nucleic acid having an aryl hydrocarbon receptor gene, wherein outgrowth of neurites is not observed without adding a substance for the aryl hydrocarbon receptor, and outgrowth of neurites is observed by adding the substance for the aryl hydrocarbon receptor. The invention also provides a method for determining the presence of neurotoxicity of a test substance, a method for acquiring a marker for determining the presence of neurotoxicity of the test substance, a method for acquiring a marker for neurological dysfunction, and a method for determining the effect of the test substance on neurological dysfunction using such cells.
Owner:KK TOSHIBA

Monoclonal cell as well as preparation method and application thereof

The invention relates to the field of cell engineering, and discloses a monoclonal cell as well as a preparation method and application thereof. The preservation number of the monoclonal cell is CCTCC NO:C2017118. The invention also discloses a method for expressing an aromatic hydrocarbon receptor. The method comprises the step of culturing the cell. In addition, the invention also discloses the application of the cell on in-vitro study of regulating an inflammatory cell factor through the aromatic hydrocarbon receptor. According to the monoclonal cell as well as the preparation method and the application thereof provided by the invention, a monoclonal cell strain for stably expressing AhR is obtained, the cell character is uniform, and the gene expression of the cell in a passage process keeps stable, so that an obtained result is more stable and reliable through utilizing the monoclonal cell strain for stably expressing the AhR for conducting an experiment.
Owner:THE THIRD AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIV OF PLA

Aryl hydrocarbon receptor antagonists and methods of use

The disclosure relates to aryl hydrocarbon receptor antagonists as well as methods of modulating aryl hydrocarbon receptor activity and expanding hematopoietic stem cells by culturing hematopoietic stem or progenitor cells in the presence of these agents. Additionally, the disclosure provides methods of treating various pathologies, such as cancer, by administration of these aryl hydrocarbon receptor antagonists. Additionally, the disclosure provides methods of treating various pathologies in a patient by administration of expanded hematopoietic stem cells. The disclosure further provides kits containing aryl hydrocarbon receptor antagonists that can be used for the expansion of hematopoietic stem cells. The disclosure further relates to pharmaceutical compositions comprising the compounds and methods of treating or preventing a disease in which aryl hydrocarbon receptor plays a role.
Owner:美真达治疗公司

Humanized recombinant vector and cell for dioxin-type substance biological detection

The invention relates to a recombinant vector and a recombinant cell, in particular to a humanized recombinant vector and recombinant cell for detecting aromatic hydrocarbon receptor ligands (such as dioxin-type substances). The invention also relates to a purpose of the recombinant vector and cell in the aspects of biological detection of aromatic hydrocarbon receptor ligands (such as dioxin-type substances). The DRE-sequence-containing human CYP1A1 gene promoters or partial segments of the promoters are cloned to a basic genetic vector with a luciferase recording gene, the obtained recombinant vector and cell have good response on the dioxin; the lowest detection limit can reach 0.3pM; the humanized recombinant vector and cell are particularly suitable for elevating the influence of the aromatic hydrocarbon receptor ligands (such as dioxin-type substances) on the human body health and performing relevant mechanism study.
Owner:RES CENT FOR ECO ENVIRONMENTAL SCI THE CHINESE ACAD OF SCI

Composition for preventing inflammations

The purpose of the present invention is to provide a probiotic(s) which can activate an aromatic hydrocarbon receptor (AhR) and can consequently prevent inflammatory damage in the digestive tract. The present invention relates to; a probiotic(s) capable of activating an AhR; an anti-inflammatory agent comprising the probiotic(s); an orally ingestible composition containing the anti-inflammatory agent; and a method for screening for the probiotic(s).
Owner:MEIJI CO LTD

Starch-indolic acid derivative, preparation method and application thereof

The invention provides a starch-indolic acid derivative, a preparation method and application thereof, and relates to the technical field of modified starch. According to the invention, the starch-indolic acid derivative is esterified starch generated by esterification reaction of starch and indolic acid under the action of a condensing agent and and alkali, has relatively high resistance, can resist degradation of the stomach and the small intestine, can release indolic acid beneficial to intestinal health through fermentation of intestinal flora after reaching the colon part, has obvious advantages compared with traditional administration modes such as intragastric administration, intraperitoneal injection and the like, and can obviously increase the content of indolic acid in colon and hepatic portal venous blood; and indoleic acid can activate an aromatic hydrocarbon receptor to play an immunoregulation role, and the indoleic acid and the regulation role of short-chain fatty acid released by fermentation of starch with intestinal flora are superposed, so that a product which synergistically plays the immunoregulation role through a plurality of immune system signal pathways is provided.
Owner:SHANDONG SHANWEI IMMUNOTECH CO LTD

2-(4-trifluoromethyl-phenylimino)-5-(2-naphthyl)methylene-thiazolidin-4-one compound and application thereof

The invention discloses a thiazole heterocyclic compound. The thiazole heterocyclic compound is 2-(4-trifluoromethyl-phenylimino)-5-(2-naphthyl) methylene-thiazolidin-4-one compound, which is referred as TNTO and has a chemical structure as shown in a general formula (I). The invention further discloses an application of the compound as an aromatic hydrocarbon receptor stimulant. Experiments prove that the thiazole heterocyclic compound under the concentration of 10 muM can remarkably up-regulate the gene, protein expression of the related exogenous substance metabolic enzyme CYP1A1 of the downstream target gene of the aromatic hydrocarbon receptor in the mouse liver cancer cells, the compound is prompted to be an agonist of an aromatic hydrocarbon receptor, and is expected to become a potential medicine which takes the aromatic hydrocarbon receptor as the tumor target, and has wide clinical application prospect and economic development value.
Owner:SHANDONG UNIV

Preparation method of skin care product composition containing camellia extract

The invention in the technical field of skin care product composition preparation discloses a preparation method of a skin care product composition containing camellia extract. The skin care product composition containing camellia extract comprises: 0.5-2 parts of RedSnow, 1 part of hydrogenated lecithin, 2 parts of methylpropylene glycol, and 1 part of Prosix EPI. Prosix EPI is used to maintain the natural barrier of skin and increase the content of NMF in the skin, methylpropylene glycol is used as a solvent to disperse RedSnow, lecithin is used as an outer phospholipid membrane lipid which emulsifies and wraps a transdermal short peptide and green algae extract to protect the effective transmission of the complex. According to the present invention, the paths of the skin problems caused by environmental pollution of aromatic hydrocarbon receptor (AhR), oxidase NADPH-oxidase 1 (NOX-1), c-Fos, and oxygenase COX-2 can be inhibited so as to improve the skin barrier function, the skin care product composition can be applied as an additive with skin repairing efficacy to mask essence liquid, essence liquid, emulsion and cream in skin care products, and the safety and stability of the product is ensured.
Owner:广州市拉凯尔干细胞研究所

1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators

The present invention relates to compounds which are 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides, their thieno-pyridone analogs, and prodrugs thereof. This invention specifically relates to such derivatives containing an N-hydrogen in the carboxanilide moiety and which exhibit modulating activity towards the aromatic hydrocarbon receptor (AhR), and, specifically, also to prodrugs thereof. The present invention also relates to use of said compounds as a medicament, and for the treatment of cancer, autoimmune disorders and other disorders with an immunological component, and a pharmaceutical composition comprising one or more of said compounds and a method of treatment.
Owner:IMMUNAHR

Methods of treating cancer with aryl hydrocarbon receptor antagonists

The disclosure relates to aryl hydrocarbon receptor antagonists, such as substituted imidazopyridines and imidazopyrazines, as well as methods of modulating aryl hydrocarbon receptor activity and treating various pathologies, such as cancer, by adminstation of these aryl hydrocarbon receptor antagonists. Additionally, the disclosure provides methods of synthesizing aryl hydrocarbon receptor antagonists, such as substituted imidazopyridines and imidazopyrazines, as well as compositions and kits containing aryl hydrocarbon receptor antagonists that can be used for the treatment of diseases and disorders.
Owner:EDIGENE BIOTECH INC

Methods of cancer treatment with 2-(1′H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester

Provided herein are methods of cancer treatment by administering an effective amount of an endogenous ligand for the aryl hydrocarbon (Ah) receptor (AhR) named ITE or one of its structural analogs to a patient with cancer, for example, prostate, liver, lung, ovarian, breast, skin, colon (or rectum), stomach, pancreatic, kidney, bladder, soft tissue, or cervical cancer.
Owner:ARIAGEN INC

Aryl hydrocarbon receptor modulators

The disclosure discloses an aryl hydrocarbon receptor modulators of formula (I), and pharmaceutically acceptable salts,R′ is H, CN, CH2(OH)R0, CmH2m+1, CnH2n-1, CnH2n-3,two Ra is independently H, or two Ra together form ═O or ═N—W3—R1; A is a C6 to C10 aromatic ring, or a C2 to C10 heteroaromatic ring containing 1 to 5 heteroatom from N, O and S, or 4 to 7 membered non-aromatic heterocyclic ring containing 1 to 3 heteroatom from N, O and S and C═N, which are with no substituent or substituted by 1 or 3 R; Q is R, or a C6 to C10 aromatic ring or a C2 to C10 heteroaromatic ring containing 1 to 5 heteroatom selected from N, O and S, which are with no substituent or substituted by 1 or 3 R; R is Rc connected with C or RN connected with N.
Owner:ARIAGEN INC

N-substituted thiazolidone compound and application thereof

The invention discloses an N-substituted thiazolidinone compound, and particularly relates to 2-phenylimino-N-(3-methoxy propyl)-5-(2, 4, 5-trimethoxy benzylidene) thiazolidinone and application of the 2-phenylimino-N-(3-methoxy propyl)-5-(2, 4, 5-trimethoxy benzylidene) thiazolidinone as a blocking agent of an aromatic hydrocarbon receptor signal channel. According to the invention, experiments prove that the compound can effectively inhibit the up-regulation of gene and protein expression of a metabolic enzyme CYP1A1 of an exogenous material related to a downstream target gene of an aromatic hydrocarbon receptor in mouse liver cancer cells caused by TCDD at the concentration of 10 [mu]M, so that it is prompted that the compound takes an aromatic hydrocarbon receptor as a target, can effectively block the activation of an aromatic hydrocarbon receptor signal channel, reduces the damage of multi-aromatic ring pollutants to an organism through the aromatic hydrocarbon receptor signal channel, and has wide clinical application prospects and economic development values.
Owner:HANGZHOU INST FOR ADVANCED STUDY UCAS

Detection method and kit

Uses of ethyl 5,11-dihydroindolo[3,2-b]carbazole-6-carboxylate as a fluorescent ligand probe, preferably in a binding assay for quantitative analysis in combination with a recombinant aryl hydrocarbon receptor (AhR) protein. A method for detection or quantitative analysis of suspected aryl hydrocarbon receptor (AhR) ligands in a sample, the method comprising the steps of: (a) providing a sample possibly containing at least one known or unknown AhR ligand; (b) mixing said sample with a composition comprising a recombinant AhR protein bound to ethyl 5,11-dihydroindolo[3,2-b]carbazole-6-carboxylate; and (c) determining the presence or the total amount of said at least one known or unknown AhR ligand in the sample by fluorescence spectroscopy. Use e.g. for screening of unknown compounds to determine their binding ability to AhR; for analyzing unknown chemical mixtures to assess the presence of ligands able to bind to AhR; for screening of Polycyclic Aromatic Hydrocarbon (PAHs) from water, food or sediment; for screening of PAHs or dioxin-like compounds in water, food or sediment; for testing for pollutant removal in water and waste water treatment plants; for testing for water reuse; for testing the presence of dioxin-like compounds in incinerator plants; or for testing of bodily fluids of humans or animals exposed to PAHs or dioxin-like compounds.
Owner:THE EURO UNION

Aryl hydrocarbon receptor activators

PendingUS20220281824A1Organic chemistryAutoimmune conditionTr1 cell
Small molecule AhR ligands are disclosed. The ligands can induce the differentiation of Tr1 cells to suppress pathogenic immune responses without inducing nonspecific immune suppression. Methods of treatment of autoimmune diseases using the AhR ligands are also disclosed.
Owner:THE STATE OF OREGON ACTING BY & THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products